相关实验视频

Updated: Jun 14, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

在乳腺癌中,GFPT1通过通过O-糖基化修改PD-L1来加速免疫逃生

Weifang Tang^1,2, Yuan Gao², Shikai Hong²

¹Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

|August 29, 2024

概括

谷氨酸果糖-6-酸盐转胺酶1 (GFPT1) 通过增强PD-L1.1的O-糖化,驱动乳腺癌 (BC) 的进展和免疫逃生. 针对GFPT1可能为BC提供新的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物化学生化学

背景情况:

免疫逃生显著导致乳腺癌 (BC) 的预后不佳.
谷氨酸果糖-6-酸盐转氨酶1 (GFPT1),是赫索胺生物合成途径 (HBP) 中的关键酶,对BC进展至关重要.
通过GFPT1影响BC免疫逃逸的精确机制在很大程度上尚不清楚.

研究的目的:

阐明GFPT1在乳腺癌进展和免疫逃生中的作用.
调查GFPT1,O-糖化和BC中的PD-L1表达之间的机械联系.
评估GFPT1作为乳腺癌的潜在治疗标.

主要方法:

使用生物信息学 (星基),qRT-PCR,西斑和免疫组织化学 (IHC) 分析BC组织中的GFPT1表达.
检测O-GlcNAc水平,并通过西部斑块和共免疫沉 (Co-IP) 检查GFPT1-PD-L1相互作用.
使用体内小鼠模型验证GFPT1在BC免疫逃脱中的作用.

主要成果:

在乳腺癌组织中,GFPT1的表达显著升高.
GFPT1调节O-GlcNAc水平,其敲击下降和过度表达增加了这些水平.
GFPT1增强了PD-L1蛋白的稳定性,并通过O-糖化依赖的机制促进BC免疫逃脱,这些发现在体内得到证实.

结论:

GFPT1通过调节O-糖基化改性PD-L1.1,促进乳腺癌的进展和免疫逃脱.
GFPT1代表了乳腺癌治疗的有前途的治疗标.

关键词:

乳腺癌乳腺癌乳腺癌总的来说,GFPT1是一个很好的方法.免疫逃脱是为了逃脱免疫.这是一种O-糖基化.在PD-L1中.

更多相关视频

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...